Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Clinical trial NCT00265330 · COMPLETED
Trial details
- NCT number
- NCT00265330
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2008-01-01
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.